PRPH
ProPhase Labs Inc. Common Stock (DE)
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$0.340
Kõrge
$0.340
Madal
$0.340
Maht
2.77M
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika
Seotud uudised
ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform
UNIONDALE, NY, June 06, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase") a next generation biotech, genomics and consumer products company, today announced the formation of its
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025
Highlights Multiple Significant Potential Liquidity Events Anticipated Within the Next Few Months Completes Significant Reductions in Overhead and Expenses BE-Smart Esophageal Cancer Test Study has been Submitted in
Seotud aktsiad
GOODN
Gladstone Commercial Corporation 6.625% Series E Cumulative Redeemable Preferred Stock
GJR
Synthetic Fixed-Income Securities Inc. STRATS Trust for Procter&Gamble Securities Series 2006-1
MAPS
WM Technology Inc.
WGSWW
GeneDx Holdings Corp. Warrant
NWPX
Northwest Pipe Company
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.